{
    "eid": "2-s2.0-85062024718",
    "title": "Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study",
    "cover-date": "2019-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Kathrin Z\u00fcrcher",
        "Marie Ballif",
        "Lukas Fenner",
        "Sonia Borrell",
        "Peter Keller",
        "Joachim Gnokoro",
        "Olivier Marcy",
        "Marcel Yotebieng",
        "Lameck Diero",
        "E. Jane Carter",
        "Neesha Rockwood",
        "Robert J. Wilkinson",
        "Helen Cox",
        "Nicholas Ezati",
        "Alash'le G. Abimiku",
        "Jimena Collantes",
        "Anchalee Avihingsanon",
        "Kamon Kawkitinarong",
        "Miriam Reinhard",
        "Rico H\u00f6mke",
        "Robin Huebner",
        "Sebastien Gagneux",
        "Erik C. B\u00f6ttger",
        "Matthias Egger",
        "Fr\u00e9d\u00e9rique Chammartin",
        "Erik C. Boettger",
        "Alash'le Abimiku",
        "Landry Wenzi",
        "Martine Tabala",
        "Robin Warren",
        "Elizabeth Streicher",
        "E. Jane Carter",
        "Carlos Zamudio",
        "Annette Sohn",
        "Tor Petersen",
        "Naruporn Kasipong",
        "Kouassi N'Guessan"
    ],
    "citedby-count": 31,
    "ref-count": 50,
    "ref-list": [
        "Global tuberculosis report 2018",
        "Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study",
        "Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes",
        "Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries",
        "Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources",
        "Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community",
        "Drug-resistant tuberculosis threatens WHO's End-TB strategy",
        "Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa",
        "Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa",
        "Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement",
        "Treatment of tuberculosis",
        "Epidemiology of antituberculosis drug resistance 2002\u201307: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance",
        "WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update",
        "Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis",
        "Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives",
        "Rapid molecular detection of tuberculosis and rifampin resistance",
        "Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa",
        "Cohort profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme",
        "Use of high burden country lists for TB by WHO in the post-2015 era",
        "Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support",
        "Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis",
        "Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis",
        "Definitions and reporting framework for tuberculosis \u2013 2013 revision (updated December 2014)",
        "Maximum likelihood estimation of the attributable fraction from logistic models",
        "Precision medicine for drug-resistant tuberculosis in high-burden countries: is individualised treatment desirable and feasible?",
        "Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF System",
        "Xpert\u00ae MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults",
        "The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis",
        "Are WHO approved nucleic acid amplification tests causing large-scale \u2018false identification\u2019 of rifampicin-resistant tuberculosis? Programmatic experience from South India",
        "The new Xpert MTB/RIF ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing",
        "Heteroresistance in Mycobacterium tuberculosis",
        "Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control",
        "Policy update. The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin",
        "Drug-susceptibility testing in tuberculosis: methods and reliability of results",
        "An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis",
        "Do HIV infection and antiretroviral therapy influence multidrug-resistant tuberculosis treatment outcomes?",
        "Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study",
        "Management of MDR-TB: a field guide. A companion document to guidelines for the programmatic management of drug-resistant tuberculosis",
        "Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa",
        "Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis",
        "WHO treatment guidelines for isoniazid-resistant tuberculosis. Supplement to the WHO treatment guidelines for drug-resistant tuberculosis",
        "Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis",
        "Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis",
        "Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis",
        "Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis",
        "Management of drug-resistant TB in patients with HIV co-infection",
        "Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting",
        "Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in southern Africa",
        "Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients",
        "A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Cape Town",
            "@id": "60000356",
            "affilname": "University of Cape Town",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000356",
            "affiliation-country": "South Africa"
        },
        {
            "affiliation-city": "Lima",
            "@id": "60111121",
            "affilname": "Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111121",
            "affiliation-country": "Peru"
        },
        {
            "affiliation-city": "London",
            "@id": "60107285",
            "affilname": "The Francis Crick Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60107285",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Bordeaux",
            "@id": "60102125",
            "affilname": "Universit\u00e9 de Bordeaux",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60102125",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Abuja",
            "@id": "60078170",
            "affilname": "Institute of Human Virology - Nigeria",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60078170",
            "affiliation-country": "Nigeria"
        },
        {
            "affiliation-city": "Eldoret",
            "@id": "60070561",
            "affilname": "Moi Teaching and Referral Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60070561",
            "affiliation-country": "Kenya"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Basel",
            "@id": "60023588",
            "affilname": "Universitat Basel",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023588",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Basel",
            "@id": "60023146",
            "affilname": "Swiss Tropical and Public Health Institute Swiss TPH",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023146",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Bern",
            "@id": "60020486",
            "affilname": "University of Bern",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020486",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Bethesda",
            "@id": "60017336",
            "affilname": "National Institute of Allergy and Infectious Diseases (NIAID)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017336",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "London",
            "@id": "60015150",
            "affilname": "Imperial College London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015150",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Zurich",
            "@id": "60012614",
            "affilname": "Universit\u00e4t Z\u00fcrich",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012614",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Columbus",
            "@id": "60003500",
            "affilname": "The Ohio State University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003500",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Zurich",
            "@id": "112607860",
            "affilname": "Swiss National Center for Mycobacteria",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112607860",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Abidjan",
            "@id": "101907150",
            "affilname": "Centre de Prise en Charge de Recherche et de Formation",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101907150",
            "affiliation-country": "Cote d'Ivoire"
        },
        {
            "affiliation-city": "Zaria",
            "@id": "100502529",
            "affilname": "National Tuberculosis and Leprosy Training Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100502529",
            "affiliation-country": "Nigeria"
        }
    ],
    "funding": [
        "Cancer Research UK, and Research Councils UK",
        "European Research Council",
        "Francis Crick Institute",
        "NIAID",
        "National Institutes of Allergy and Infectious Diseases",
        "National Research Foundation of South Africa",
        "National Research University Program",
        "Office of the Higher Education Commission",
        "Swiss National Center for Mycobacteria",
        "Swiss National Science Foundation",
        "UK Medical Research Council",
        "University of Zurich",
        "Wellcome Trust",
        "Wellcome Trust",
        "Francis Crick Institute",
        "European Research Council",
        "Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung"
    ]
}